CA1280368C - 6h,7,8-dihydrothiapyrano(3,2d) pyrimidines utilisees comme agents hypoglycemiques - Google Patents

6h,7,8-dihydrothiapyrano(3,2d) pyrimidines utilisees comme agents hypoglycemiques

Info

Publication number
CA1280368C
CA1280368C CA000522047A CA522047A CA1280368C CA 1280368 C CA1280368 C CA 1280368C CA 000522047 A CA000522047 A CA 000522047A CA 522047 A CA522047 A CA 522047A CA 1280368 C CA1280368 C CA 1280368C
Authority
CA
Canada
Prior art keywords
nitrogen
joined
hydrogen
heterocycle
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000522047A
Other languages
English (en)
Inventor
Richard Saperstein
Eve E. Slater
Richard L. Tolman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to CA000522047A priority Critical patent/CA1280368C/fr
Application granted granted Critical
Publication of CA1280368C publication Critical patent/CA1280368C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000522047A 1985-11-04 1986-11-03 6h,7,8-dihydrothiapyrano(3,2d) pyrimidines utilisees comme agents hypoglycemiques Expired - Lifetime CA1280368C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000522047A CA1280368C (fr) 1985-11-04 1986-11-03 6h,7,8-dihydrothiapyrano(3,2d) pyrimidines utilisees comme agents hypoglycemiques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US794,889 1985-11-04
CA000522047A CA1280368C (fr) 1985-11-04 1986-11-03 6h,7,8-dihydrothiapyrano(3,2d) pyrimidines utilisees comme agents hypoglycemiques

Publications (1)

Publication Number Publication Date
CA1280368C true CA1280368C (fr) 1991-02-19

Family

ID=4134281

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000522047A Expired - Lifetime CA1280368C (fr) 1985-11-04 1986-11-03 6h,7,8-dihydrothiapyrano(3,2d) pyrimidines utilisees comme agents hypoglycemiques

Country Status (1)

Country Link
CA (1) CA1280368C (fr)

Similar Documents

Publication Publication Date Title
EP0629602B1 (fr) Dérivés de 3,4-Dihydroxychalcone
CA1302275C (fr) Inhibiteur enzymatique
HU220669B1 (hu) Eljárás diabéteszes szövődmények kezelésére vagy megelőzésére szolgáló gyógyászati készítmények előállítására
JPWO1994005283A1 (ja) 抗ｈｉｖ剤
US5614542A (en) Thiazolidine derivatives having anti-hypertensive activity and their therapeutic use
US6399658B1 (en) Composition containing ascorbic acid
EP0983765B1 (fr) Remedes preventifs ou therapeutiques contre les maladies associees a une anomalie fonctionnelle vasculaire en relation avec la resistance a l'insuline
KR100310121B1 (ko) 티아조푸린및리바비린을사용하는종양질환의치료방법
CA1280368C (fr) 6h,7,8-dihydrothiapyrano(3,2d) pyrimidines utilisees comme agents hypoglycemiques
US4876256A (en) Alkylpiperazinylpyridines as hypoglycemic agents
US4978667A (en) Substituted 6H-7,8-dihydrothiapyrano(3,2-d)-pyrimidines as hypoglycemic agents
EP0224722B1 (fr) Utilisation des 6H-7, 8-Dihydrothiapyrano[3,2-d]pyrimidines pour obtenir des medicaments utiles comme médicaments hypoglycémiques ou comme agents d'amaigrissement pour des patients obèses
CA1313139C (fr) D1-5[(2-benzyl-3,4-dihydro-2h-benzopyran-6-yl)methyl] thiazolidine-2,4-dione, utilisee comme agent antisclerose
EP0543018A1 (fr) Agent antidiabetique
CS212264B2 (en) Method of making the 5-m-tolyloxyuracile
Keung et al. Single-dose pharmacokinetics of rifapentine in elderly men
EP0410305B1 (fr) Usage des dérivés du bis(4-hydroxyphénylthio)méthane dans le traitement du diabète sucré
US4880811A (en) Use of C-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
EP0199888A2 (fr) Contrôle des concentrations du hème et du fer dans les tissus du corps
US6531461B1 (en) Medicament for the treatment of diabetes
WO1991013623A1 (fr) Barbituriques monosubstitues en c-5 combines a des agents therapeutiques et leurs emplois
US4895843A (en) Use of 3-(4-bromo-2-fluorobenzyl)-4-oxo-3H-phthalazin-1-ylacetic acid as a hypouricaemic agent
EP0298465B1 (fr) Médicament pour le traitement du diabète
Eisman et al. The antituberculous activities of substituted thiazolines and thiazolidinones
EP0324520A2 (fr) Alkyl-pipérazinyl-5,6-alkylènepyrimidines

Legal Events

Date Code Title Description
MKLA Lapsed